Hendra viruses, produce a mixture of virus-particle sizes including very long, filamentous members 1-4 . However, the function of the filamentous particles is unknown. The main impediments to characterizing viral filaments are their phenotypic origin (a single infecting particle gives rise to a range of particle sizes) 5,6 , difficulty of purifying particles to homogeneity according to their size, and the apparent lack of filament advantage in vitro 7,8 . Influenza virus particles range in length by three orders of magnitude (~55 nm to ~30 µm). All influenza particles package at most a single genome, but the total number of the surfaceexposed viral glycoproteins, hemagglutinin (HA) and neuraminidase (NA), and the HA/NA ratio scale with particle length 6,9,10 . HA is the cell-entry protein of influenza, which mediates fusion between the viral and the endosomal membranes by the combined action of 3-5 active HA neighbors (fusion cluster) 11-13 . Here we identify influenza filaments as viral persisters increasing the probability of fusion-cluster formation and cell entry under HA-directed selective pressure. We fractionated viruses to enrich for spherical or filamentous particles and measured the single-particle kinetics of membrane fusion. As a surrogate for HAdirected selective pressure, we used a Fab fragment of a broadly neutralizing antibody that inactivates bound HA 14 . In its presence, filamentous particles fuse more rapidly and more efficiently than do spherical ones. We show that the infectious advantage of filaments derives from their enhanced fusion efficiency rather than from rate effects. Filaments also offer universal protection from extreme HA inactivation. Our results show how the virus can adapt to any condition limiting HA function, and suggest targeting viral filaments as a strategy to prolong vaccine effectiveness or to thwart viral pandemic adaptation.
INTRODUCTION
Viruses present tractable systems with which to dissect universal mechanisms. The phenomenon of phenotypic diversity that benefits a population under changing pressure is known even among higher organisms 15 , and is best studied in bacteria, where the role of bacterial persistence in antibiotic resistance is well documented 16, 17 . Persisters are defined as a small subpopulation of bacteria that survive antibiotic treatment, but after antibiotic removal, expand into a population with the same antibiotic sensitivity as the original population. Under sustained pressure, persisters give rise to (genetic) resistance. The molecular players that generate diversity are in some cases starting to emerge 17 . However, defining the underlying mechanisms that confer benefit under a given set of conditions is challenging because of the small numbers and phenotypic origin of the beneficial members. The relative simplicity of viral structure might offer a tractable system with which to probe functional differences among members.
Influenza filaments are advantageous and persist in vivo, but are quickly replaced by spherical particles during virus passaging in vitro 18, 19 . Spherical particles are taken up by cells via clathrin-mediated endocytosis, and filaments via a slower and more energy-requiring macropinocytosis 20 . Furthermore, the assembly of filaments takes up tremendous resources (e.g. membranes and viral proteins), but they package the same, single-genome cargo 9, 10, 21 . It is thus assumed that to understand the benefit of viral filaments, a full complexity of in-vivo infections needs to be considered. However, the relative simplicity of virus structure offers hints into the filament function. Influenza virus has three structural proteins whose numbers scale with particle size: the matrix protein, M1, which forms the particle shape, and the surface-exposed HA and NA 9, 10 . HA densely covers at least 80% of the viral surface and its relative representation is higher on longer particles at the expense of NA 6, 9, 10 . HA is the main target of neutralizing antibodies and is thus under constant pressure to evolve 22 . Furthermore, adaptation of HA to human-cell entry is a key determinant of influenza pandemics, so viral zoonotic transmission is another source of selective pressure on HA 23 . Presentation of HA on particles of different sizes might offer an adaptability benefit, and detailed dissection of HA function in different particle contexts should reveal its mechanism.
HA is synthesized as an inactive trimer, HA0 24 . Activation requires cleavage of each HA0 monomer into two disulfide-linked subunits, HA1 and HA2 25 . For cell entry, HA1 engages the sialic-acid receptor on the target-cell surface, and HA2 mediates membrane fusion in the late endosome. Individual HA1-sialic acid interactions are weak (2-3 mM K d ), but multivalent virus binding results in femtomolar avidities 26 . The contact interface (patch) between the virus particle and the membrane incorporates ~50 HAs for the spherical particles, and this number scales approximately linearly with particle length [9] [10] [11] (Fig. 1a ). Membrane fusion results from a functional interplay among HAs within the contact patch. Cleaved HA is metastable; low pH reduces the barrier for transition to the stable postfusion conformation 27 . Initial HA triggering is stochastic, but inducing membrane merger requires the combined free energy released by the HA conformational changes of 3-5 neighboring trimers 11, 12 . A hydrophobic peptide sequence at the Nterminus of HA2, termed the fusion peptide (FP), mediates functional coupling of HA conformational changes to membrane fusion. In the pre-fusion HA, FP inserts in a conserved cavity (the pre-fusion pocket) at the base of HA near the viral membrane 24 . During HA conformational changes in the contact patch, FP either inserts in the target membrane (productive HA), or, if HA assumes the post-fusion state without engaging the target membrane, FP inserts back into the viral membrane (unproductive HA) 12, 28 . The release of FP from the pre-fusion pocket is the rate-limiting structural rearrangement influencing the rate of fusion-cluster formation 11 . The frequency of unproductive HAs, which imposes restrictions on the available geometries for adjacent HA insertions, influences the rate and probability of fusion-cluster formation 12, 29 . While membrane resistance prevents individual inserted HAs from folding back, the fold-back for HAs in the fusion cluster is cooperative and fast 11 .
Prediction from stochastic simulations
The larger patch size afforded by viral filaments should increase the total number of inserted HAs and thus the efficiency and/or rate of membrane fusion under any condition limiting HA activity, e.g. large fraction of unproductive HA, low level of HA0 activation, or HA inactivation by antibodies or inhibitors ( Fig. 1a ). To express these predictions in quantitative terms, we performed stochastic simulations of fusion for a 600-fold range of patch sizes and zero to 80-97% HA inactivation (Fig. 1b ). The probability of fusion-cluster formation for spherical particles declines for HA inactivation greater than 20% (PS 55), but a 600-times larger patch requires at A simplified contact patch before fusion (t 0 ) or at the time of fusion-cluster (FC) formation (t hemifusion ) is shown (top). Random HAs extend and insert into the target membrane (green -pre-fusion HA; magenta -inserted HA) or become inactivated (black -unproductive HA). k e is the rate of FP release. Under the same limiting condition, longer particles have a higher probability of fusioncluster formation (bottom). The prediction is illustrated with an elliptical patch, but the simulations used circular patches (see Methods). b, Simulation results for the yield and mean lag-time to fusion-cluster formation at 0.02-0.1 inactive HA-fraction increments from datasets with at least 1000 fusion clusters. PS, patch size. least 90% HA inactivation for the same effect, and yields 20% fusion for 97% inactive HAs (PS 34627). Larger patches form fusion clusters more rapidly, but rate differences get smaller for more HA inactivation. Overall, larger patch size enables higher efficiency and/or rate of fusion-cluster formation depending on the extent of HA inactivation.
Functional advantage of filaments
To compare the predictions from stochastic simulations with experiment, we used filamentous influenza virus, X31HA/Udorn, in single-particle experiments of membrane fusion 11 . Analysis of individual particles can reveal subpopulations with distinct kinetics, and in this way obviate the need for homogeneous particle preparations. We devised a strategy for particle sizeenrichment using cycles of centrifugation at low relative centrifugal force, which preferentially sediments filamentous particles. We analyzed the resultant fractions by negative-stain electron microscopy ( Fig. 2a-b , Tables 1 and 2 ). The supernatant fraction (SUP) has a relatively narrow and symmetric particle-size distribution, with 95% of the population ranging in length from 50 nm to 250 nm. Taking 250 nm as the cut off, the pellet fraction (PELLET) includes 47.2% filaments, whose average length is ~5-times that of the SUP particles (Table 1) .
To produce a variable, measurable limit to HA activity, we used a Fab fragment of a broadly neutralizing antibody, MEDI8852 (M-Fab), which binds the base of HA and prevents HA conformational changes 14 . Fluorescently tagged M-Fab binding to unlabeled particles shows a narrow distribution of particle intensities for the SUP particles, and a wider fluorescence-intensity distribution with a long tail for the PELLET particles ( Fig. 2c ). M-Fab binding thus scales with particle length. Incubation of M-Fab-bound particles at low pH did not significantly change fluorescence-intensity distributions ( Fig. 2c) , validating M-Fab as a reagent that inactivates targeted HA for at least the duration of these experiments, an assumption of stochastic simulations ( Fig. 1 ).
We performed membrane fusion experiments with DiD-labeled SUP or PELLET particles on supported planar membrane bilayers for a range of unlabeled M-Fab concentrations at pH5.2 (Supplemental Videos 1-4). We extracted individual-particle lag times from pH drop to hemifusion (onset of DiD dequenching), a fusion intermediate that reports on fusion-cluster formation and invariably precedes pore opening 11, 30 . We fitted frequency distributions of hemifusion lag times with gamma probability density and derived mean lag times from the fits 12, 30 (Fig. 3a ). The plots of hemifusion yield and time for a range of M-Fab concentrations both show that the PELLET particles are less sensitive to HA inactivation than the SUP particles ( Fig. 3b ). We derived hemifusion yield and lag-time distributions for the long (>250 nm) particles within the PELLET as described in the Methods (Fig. 3c ). The resultant plots of SUP versus long particles match the prediction from stochastic simulations for patch-size pairs where the larger patch size is ~4-5 times the size of the smaller one (e.g. 55/235 or 121/583) ( Fig. 1b) ; the derived patch-size ratio in turn agrees with the measured ratio of the filament and SUP-particle average lengths ( Table 1 ). The combined results thus validate the stochastic fusion model 12 , and support our hypothesis that the larger patch size afforded by viral filaments increases the rate and probability of fusion-cluster formation under limiting HA activity. Biotinylated antibody targeting HA1 is specifically captured with neutravidin, and it recruits virus particles. Virus particles were pre-incubated with 134 nM JF-549-tagged M-Fab before capture, and unbound M-Fab was washed away after capture. Representative particle-images (left), and particle fluorescence-intensity quantification at neutral pH (middle), or after 20 minutes at pH 4.8 (right). 
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Increased infectivity of filaments
To determine whether viral filaments offer infectivity advantage under HA-directed selective pressures, we measured the SUP-and PELLET-particle concentrations (in hemagglutination units per ml; HAU/ml) needed to induce 50% cell death for a range of M-Fab concentrations in a single-cycle of infection (scTCID 50 ) ( Fig. 4 ). We limited infections to a single cycle because particle-size separation is possible only for the initial infection, which then yields pleomorphic progeny 5, 6 . In the absence of inhibition, the PELLET has no infectivity advantage (and in some experiments a subtle disadvantage) over the SUP (Fig. 4a ), consistent with previous reports for viral filaments 7, 8 . However, the effect of M-Fab on the scTCID 50 of the PELLET is lower than its effect on the SUP, with the PELLET advantage ranging from 50% (17 nM M-Fab) to greater than 3-fold (268 nM M-Fab) (Fig. 4b ). The scTCID 50 data confirm that influenza virus sensitivity to HA inhibition decreases with increase in virus-particle length. 
Effect of HA inactivation on infectivity
The protective effect of filaments for a given level of HA inactivation could stem from their increase in the fusion rate, yield, or both ( Fig. 3c ). To test whether kinetics of fusion-cluster formation influences infectivity outcomes, we employed virus mutants with (de)stabilized prefusion HA. A mutation in HA2, D112 2 A, destabilizes FP in its pre-fusion pocket resulting in faster hemifusion 11 . A mutation in HA1, H17 1 Y, stabilizes FP in its pre-fusion pocket and is predicted to slow hemifusion 31 . The extent of fluorescent M-Fab binding to WT and D112 2 A particles is the same, and to H17 1 Y only slightly reduced, implying the same or very similar extent of HA inactivation for a given M-Fab concentration (Fig. 5a ). Indeed, single-particle measurements for WT and D112 2 A give very similar hemifusion-yield curves, and a similar relative change in hemifusion lag-times ( Fig. 5b ). However, D112 2 A particles are 7 to 11 times faster in hemifusion for the tested range of M-Fab concentrations, owing to the faster rate of fusion-peptide release for the mutant 11 . At even the highest M-Fab concentration, hemifusion of D112 2 A particles is 2.4-fold faster than that of the uninhibited WT. H17 1 Y, on the other hand, is so stabilized that it has lower hemifusion yield at pH 5.2, either because of a lower extent of HA activation or lower productiveness ( Fig. 5c ). At pH 4.8, hemifusion yield of H17 1 Y is comparable to WT, but hemifusion rate is markedly lower for the mutant. Unlike the large changes in the rate of hemifusion for HA mutations, even the highest concentration of M-Fab tested slows hemifusion of the short particles less than 5-fold ( Fig. 3b , 5b-c). Thus, the HA mutants allow us to probe the effects of altered hemifusion-rates on infectivity.
We compared WT, D112 2 A, and H17 1 Y viruses in scTCID 50 experiments ( Fig. 5d-f ). The baseline titers of D112 2 A and H17 1 Y viruses are within 2-3-fold of WT, showing that cell entry is relatively insensitive to the rate of fusion-cluster formation (Fig. 5d ). Furthermore, WT and D112 2 A viruses are equally sensitive to all tested M-Fab concentrations, confirming that the rate increase afforded by HA destabilization does not boost infectivity under HA pressure ( Fig. 5e ). H17 1 Y is more sensitive to HA inactivation than WT and D112 2 A viruses, but otherwise follows the same trend for the higher M-Fab concentration (Fig. 5e ). The higher sensitivity of H17 1 Y to M-Fab can be interpreted in the context of this mutant's lower hemifusion yield at the pH of endosomes (Fig. 5c, pH 5.2 ). If the lower rate of fusion-cluster formation for H17 1 Y contributed to its higher sensitivity to M-Fab, a further increase in M-Fab concentration would inhibit H17 1 Y disproportionately, causing it deviate from the WT/D112 2 A infectivity curves. The same infectivity trend for H17 1 Y confirms that cell entry of even the slow-fusing H17 1 Y mutant is insensitive to rate changes caused by HA inactivation (Fig. 5e ). M-Fab thus lowers infectivity by lowering the number of particles that successfully assemble fusion clusters.
Filaments resist extreme HA inactivation
The unproductive HA fraction contributes to the overall probability of virus particles assembling fusion clusters and determines how sensitive particles will be to HA inactivation (Fig.  1a) 12, 29 . The effect of M-Fab on fusion-cluster formation in endosomes (Fig. 5e ) is much greater than its effect in vitro (Fig. 5b-c) . For example, 67 nM of M-Fab reduces scTCID 50 titers 14-fold for the WT and D112 2 A SUP particles, but hemifusion-yield changes are comparably small for this M-Fab concentration in vitro. Productive HAs are thus less frequent in endosomes than on planar membrane bilayers, and inactivation of a small subset of HAs prevents a majority of virus particles in endosomes from assembling fusion clusters.
The effect of M-Fab on the scTCID 50 of D112 2 A or H17 1 Y PELLET is lower than its effect on the corresponding SUP, with PELLET advantage being the same for the mutants as for the WT (Fig. 5e-f ). We interpret PELLET advantage as resulting from more opportunities for fusion- cluster formation on longer particles (Fig. 1a ). This interpretation predicts that infectivity differences between PELLET and SUP fractions would be greater for HA-inactivation levels that affect very long filaments because PELLET and SUP particle distributions are more different for longer particles (Table 2) . To test this prediction, we prepared virus particles with less than 1% activating HA0 cleavage (Fig. 6a ). We then measured the loss of infectivity for the uncleaved virus, or the uncleaved virus pre-treated with M-Fab, relative to fully cleaved, untreated virus in a modified plaque-assay experiment (Fig. 6b) . The result for the control (cleaved, M-Fab pretreated) virus matched the scTCID 50 data at this M-Fab concentration (Fig. 4) with the PELLET offering approximately 3-fold higher infectivity than the SUP (Fig. 6b) . A similar result was obtained for the uncleaved virus. Consistent with our prediction for extreme HA pressure, the uncleaved, M-Fab pre-treated PELLET is at least 10-times more infectious than the corresponding SUP. Since at really high HA inactivation levels the rate of fusion-cluster formation approaches a plateau (Fig. 1b, Fig. 3 ), this result supports our interpretation that the PELLET advantage derives from an increase in the fusion yield. In sum, bulk endosomal fusion is unproductive and exquisitely sensitive to small perturbations in active-HA numbers. Filaments resist HA inactivation by having more opportunities for fusion-cluster formation. Very long filaments enable cell entry when active HAs become extremely rare independent of the reasons for low HA function (presence of inhibitors or near absence of activating HA cleavage); in this way, they facilitate replication allowing for mutations that can lead to adaptation.
Conclusions
Our results define influenza filaments as viral persisters under general HA pressures. We propose a model for viral particle-size diversity serving as a phenotypic switch in the changing environment ( Fig. 7) . At low relative HA-directed selective pressure, majority of new infections are initiated by spherical particles; they are more numerous, use fewer resources, and are faster to internalize and assemble ( Fig. 7a) 6, 8 . Filaments take over when HA function is limiting and permit low level of replication (Fig. 7b ). If pressure is removed, the same viral population can expand. Under sustained pressure, viral replication initiated by filaments can lead to (genetic) adaptation. For example, filaments might enable low level of replication under immune pressure, and even permit inefficiencies in HA function for immune evasion mutants, which can then be repaired by mutation. Similarly, early zoonotic transgressors in humans might be permitted by the filamentous virus population, then improved by mutation. Targeting filamentous influenza particles should extend the effectiveness of vaccinations or fusion inhibitors, as well as help curb viral pandemics arising from adaptation of new influenza strains. One way to achieve that is to target the molecular pathways that enable filament assembly. For example, NA inhibitors disproportionately affect the release of filaments because of the higher relative NA-content on spherical particles 6 . Combining HA and NA inhibitors might thus delay resistance in an unanticipated way because NA pressure increases the proportion of spherical particles, ready targets for HA inhibitors. An attractive target for delaying resistance to HA pressures might also lie in the unique cell biology of large-cargo internalization (i.e. macropinocytosis) (Fig. 7c) 20, [32] [33] [34] [35] [36] . Targeting cellular factors required for filamentous-virus internalization would both curb avenues for resistance by targeting host processes, and provide broad-spectrum effect against filamentous virus pathogens 1-4 .
SUPPLEMENTAL VIDEOS LEGENDS
Supplementary Video 1 | A sample video of the SUP hemifusion at pH 5.2 and no M-Fab.
Exposure time is 0.5 sec and the video is at 80 frames per second (fps).
Supplementary Video 2 | A sample video of the PELLET hemifusion at pH 5.2 and no M-Fab.
Exposure time is 0.5 sec and the video is at 80 frames per second (fps). The same strategy might apply to extending vaccine effectiveness or preventing zoonotic adaptations that can lead to pandemics. Circles, spherical particles; Ellipses, filaments; Blue, WT; Black/Orange/Green, HA mutants; Red, an adaptive HA mutant; CME, clathrinmediated endocytosis.
Supplementary Video 3 |
METHODS
Reagents
Cells. MDCK.2 cells (ATCC strain CCL-34) were propagated in DMEM supplemented with 10% FBS. All infections were performed in OptiMEM (ThermoFisher Scientific) with or without 1 µg/ml TPCK-trypsin (Sigma) or M-Fab. Human embryonic kidney 293F cells were a generous gift from Stephen C. Harrison, Harvard Medical School. 293F cells were maintained in FreeStyle 293 Expression Medium (ThermoFisher Scientific), and used for Fab expression.
Antibodies. Hybridomas for SiteA and A2 antibodies were a generous gift from Judith M. White, University of Virginia. Purified LC89 antibody was a generous gift from Stephen A. Wharton, MRC National Institute for Research, London, UK. SiteA antibody binds an epitope on the HA1 head accessible on both the pre-and post-fusion HA. A2 detects an epitope on the low-pH HA1, and LC89 detects the low-pH helix-to-loop transition in HA2, residues 106-112 28 ; both are reactive with HA0 and either HA1 or HA2 in Western blot.
Stochastic simulations
We used our previously published simulation codes without modification 12 . Simulation were run using the following input parameters: 1) k e = 0.003sec -1 , where k e is the rate of fusion peptide release, 2) f un = 0.5, where f un is the unproductive HA fraction, 3) N h = 3, where N h is the number of HA neighbors in the fusion cluster, 3) f in = 0 to 0.97, where f in is the inactive HA fraction in 0.02-0.1-value increments, and 4) input values for patch size of 50, 100, 200, 500, 1000, 3000, or 30000, to obtain actual patch sizes of 55, 121, 235, 583, 1159, 3463, or 34627, respectively. The shape of the contact patch in the simulation was kept as a circle because both unproductive and inactive HAs subdivide the area into small segments rendering the overall starting shape irrelevant for the measured outcomes.
Viruses
Viruses have A/Aichi/68 (X31) HA and the remainder of the segments from A/Udorn/72 37 . D112 2 A mutant was characterized previously 11 . H17 1 Y mutant was made and grown according to our D112 2 A protocol 11 , except that it was passaged at a higher multiplicity of infection (MOI) of 0.1 before the final, MOI 12 infection that was not modified. Uncleaved virus was generated as described for the cleaved virus 37 except that trypsin was omitted in the final, MOI 12 infection before purification. Purifications of the short WT, D112 2 A, and H17 1 Y viruses used in Fig. 5a -c were done according to our previous short-particle purification protocol on 20-60% sucrose gradient 37 . For the pelleting protocol, viruses were passed through a 30% sucrose cushion as before 37 , and then subjected to 8 cycles of centrifugation at 3250 rcf for 1.5 hrs at 4 °C. For each spin, virus was diluted to 900 µl HNE20 (20 mM HEPES NaOH pH 7.4, 150 mM NaCl and 0.2 mM EDTA). After each spin, 850 µl of the supernatant volume was removed, and the pellet was resuspended in HNE20 over 6-14 hours at 4 °C. The final, 8 th -spin pellet constitutes PELLET. Supernatants were combined and concentrated by a 1-hr spin at 100,000 xg (SUP).
All viruses were stored in HNE20. All purified viruses were sequenced to confirm HAsegment correctness. Completeness or near-absence of HA cleavage/activation on the purified cleaved or uncleaved virus preps was verified by A2-antibody Western blots 12 . Each virus passage and each virus manipulation (e.g. fluorescent labeling, pelleting fractionation) were followed by measurements of specific virus infectivity using a combination of the standard plaque and hemagglutination (HA) assays to ensure a constant ratio of plaque forming units (PFU) to HA units (HAU reports on the physical virus-particle count independently of the particle morphology -see under Electron microscopy). A typical PFU/HAU ratio for the viruses is ~1-5E4. Total protein concentration of the purified virus preps was determined by the Bradford assay (BioRad).
Electron microscopy
PELLET fractions were adjusted to 2e4 HAU/ml, and SUPs and short gradient-purified fractions were adjusted to 1e5 HAU/ml. As a precaution, viruses were pretreated with 25 µM rimantadine (M2 inhibitor, Sigma) for 30 minutes at room temperature (RT) to prevent fragmentation of the filamentous particles 20 . 2% phosphotungstic-acid staining was performed as previously described 37 . Images were taken on Philips Morgagni Version3.0 TEM (80 kV, 1k CCD) using AMT Camera Version 600.335o software. Particle-size measurements were performed using custom MATLAB codes as previously described 37 .
To test whether HA-assay measurements accurately report on virus-particle counts for the PELLET and SUP fractions, we performed EM-based particle counting as follows. PELLET and SUP fractions diluted as above were each mixed with a fixed concentration of purified reovirus particles. Reovirus particles have regular icosahedral structures ~85-nm in diameter 38 , and appear as distinct, regular, darker objects, clearly distinguishable from influenza virus particles in the negative-stain electron micrographs. 1000-3000 total particles were counted to determine the SUP/reo and PELLET/reo particle ratios. The resultant value for PELLET/SUP particle ratio closely matched (within 30%) the PELLET/SUP particle ratio derived from their respective input HAU/ml. We therefore used HA-assay values to represent a measure of input physical particles in experiments independent of the particle morphology.
M-Fab expression, purification and labeling
The expression vectors (modified pVRC8400) for MEDI8852 Fab light and heavy chains were a generous gift from Stephen C. Harrison, Harvard Medical School. The heavy-chain construct contains the C-terminal 6xHis tag. For the fluorescent labeling of M-Fab, we modified the heavychain construct to also include a Sortase recognition motif LPETGG between the heavy-chain sequences and the 6xHis tag. Fab fragments were produced by transient transfection of 293F cells with polyethylenimine (PEI) (1 ug DNA: 1.5 ug PEI: 1E6 cells). Fabs were purified from the culture supernatants 5 days post transfection by a passage over a HisTrapFF column (GE Healthcare) followed by gel filtration chromatography on Superdex 200 Increase (GE Healthcare) in PBS.
A 10-fold molar excess of GGGK peptide (GenScript) was labeled with JF549-NHS-ester dye (Tocris Bioscience) in 100 mM sodium bicarbonate (pH 8.4) buffer. The desired peptide, singly labeled at the lysine residue was purified by reverse-phase HPLC on a C18 column (Grace) and its identity was confirmed by LC/MS and by its reactivity with LPETGG-M-Fab in the Sortase-labeling reaction. 6xHis-tagged SortaseA5 was expressed in E.coli BL21(DE3) cells and purified as previously described 39 . A 1: 1: 25 molar ratio of SortaseA5: LPETGG-M-Fab: GGGK-JF549 was used for the Sortase-labeling reaction in PBS supplemented with 5 mM CaCl 2 and 5 mM MgCl 2 for 30 minutes at RT. Unreacted LPETGG-M-Fab and Sortase still retaining the 6xHis tag were removed from the labeled product using NiNTA resin in PBS containing 10-30 mM imidazole buffer. M-Fab-JF549 product was buffer exchanged into PBS.
Single-particle experiments
Hemifusion. We used the protocol for influenza membrane fusion described previously 11 with modifications. Virions were labeled in 25-µl reactions at 0.24 mg/mL with 1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindodicarbocyanine, 4-Chlorobenzenesulfonate Salt (DiD, ThermoFisher Scientific) at 10 µM for 1.5 hours at RT. Labeled virions were used within one week. Liposomes used for planar bilayer generation consisted of 4:4:2:0.1:2 × 10 −4 ratio of 1, 2, dioleoyl-sn-glycero-3-phosphocholine (DOPC) (Avanti Polar Lipids), 1-oleoyl-2-palmitoyl-sn-glycero-3phosphocholine (POPC; Avanti Polar Lipids), sn-(1-oleoyl-2-hydroxy)-glycerol-3-phospho-sn-3'-(1'-oleoyl-2'-hydroxy)-glycerol (ammonium salt) (18:1 BMP (R,R)) (Avanti Polar Lipids), bovine brain disialoganglioside GD1a (Sigma), and N-((6-(biotinoyl)amino)hexanoyl)-1,2dihexadecanoyl-sn-glycero-3-phosphoethanolamine (biotin-X DHPE) (Molecular Probes, Life Technologies), where sialic acid residues on GD1a served as receptors for influenza virions. Briefly, as before 11 , planar bilayers were generated from 200-nm liposomes by vesicle-spreading method within the channels of a PDMS flow cell. They were labeled with fluorescein-conjugated streptavidin (30ug/ml, Invitrogen) that served as an external pH-probe. DiD-labeled virions (untreated or treated with M-Fab for 20 min at RT) were attached for 5-15 min. Unattached virions were washed with HNE20, and the pH was dropped with pH-4.8 or pH-5.2 buffers (10 mM citrate, 140 mM NaCl and 0.1 mM EDTA). For M-Fab-treated samples, M-Fab was included in the low pH buffer, and after 3 min of the low-pH buffer flow at 60 µl/min, the flow was reduced to 6 µl/min to preserve M-Fab. We followed hemifusion as a spike in individual virion fluorescence resulting from DiD-fluorescence dequenching upon dilution in the target membrane. All experiments were performed at 23±0.4 °C.
Fluorescent M-Fab binding. Cleaned and plasma etched slides 11 were silanized with N-(2aminoethyl)-3-aminopropyltrimethoxysilane, amino silane (United Chemical Technologies) and then PEGylated with a mixture of biotin-PEG-SVA-5000 and mPEG-SVA-5000 (1:40 molar ratio; Laysan, Inc.) according to a published protocol 40 . They were dried and stored protected from light and moisture at -80 °C until use. For fluorescent M-Fab binding experiments, PDMS flow cells were assembled as before 11 and the following sequence of steps was followed each time: 1) PBS wash, 5 min at 30 µl/min; 2) 5-min incubation with 0.2 mg/ml NeutrAvidin (ThermoFisher Scientific); 3) PBS wash, 2 min at 30 µl/min; 4) 6-min incubation with biotinylated SiteA antibody (0.1 mg/ml); 5) PBS then HNE washes, 2 min at 30 µl/min each; 6) imaging for background subtraction; 7) 7-min incubation with unlabeled virions pre-incubated with M-Fab-JF549 for 20 min at RT; 8) HNE20 wash, 30 sec at 30 µl/min; 9) imaging for intensity measurements, pH7.4 (4 fields of view); 10) pH-4.8 buffer wash, 3-min at 60 µl/min, and incubation for the total of 20 min; 11) imaging for intensity measurements, pH4.8 (4 fields of view, including one shared with pH7.4imaging). When SiteA antibody was replaced by a non-specific mouse antibody, a very small amount of nonspecific sticking of influenza virus particles was observed (~1%).
Microscope configuration. The excitation pathway was unchanged relative to our previous setup 11 , except that we now added a 647-nm laser (Obis, Coherent) and the diameter of the illuminated area was approximately 136 µm. Total internal reflection (TIR) illumination was achieved using a commercial micro-mirror platform, RM21 (Mad City Labs, Inc.) essentially as described 41 . Briefly, the system spatially separates the excitation and emission light within the objective lens and eliminates the need for a dichroic. An integrated XY micro-positioning, and XYZ nano-positioning stage is designed around a fixed objective lens (Olympus 60X ApoN NA=1.49) with the open access to its back aperture required for micro-mirror-based illumination. The system was additionally equipped with a 180-mm achromatic tube-lens. Image was projected onto an entire 512 x 512 pixel EM-CCD sensor (Model C9100-13; Hamamatsu) for the final pixel representation of 160 nm. For the single-particle hemifusion experiments, 488-nm laser (Obis, Coherent) was used to excite fluorescein, and 647-nm laser (Obis, Coherent) was used to simultaneously excite DiD. The power of the 488-nm laser was 1-2 µW, and the 647 laser was 0.25-1 µW over the illuminated area. Exposure time was between 0.4 and 0.8 sec, depending on the virus and the inhibitor concentration. For the fluorescent intensity measurements of M-Fab-JF549 binding to virus particles, the power of the 552-nm laser was 5.1 µW over the illuminated area, and the exposure time was 1 sec.
Data analysis
All data analysis was done in MATLAB (MathWorks).
Single-particle hemifusion. Particle centroids, pH-drop time, and DiD-dequenching times for individual particles were extracted from time-lapse movies as described 30 . We defined hemifusion yield as the percent of detected particles that hemifused within 20 minutes of pH drop. Probability-density distributions of hemifusion lag times were fitted with gamma distribution to derive mean lag-times 12, 29, 30, 37 .
Derivation of long-particle hemifusion kinetics. Hemifusion-yield curves for PELLET and SUP particles (Fig. 3b ) were scaled to adjust the no-M-Fab hemifusion to 100%. We justify this in the context of our previous analysis, which found that the lower than 100% yield in the absence of HA inhibition reports on the efficiency of the assay, but the probability of fusion-cluster formation is 100% 12 . This assumption is further justified by PELLET maintaining unreduced hemifusion yield at 67 nM M-Fab (Fig. 3b) ; if fusion-cluster formation was already limiting for no M-Fab, HA inactivation would cause a further reduction in hemifusion yield (Fig. 1b) 12 . In what follows, we illustrate with one example how the scaled yield-data were then processed to derive long-particle yields. At 268 nM M-Fab, there is 80% (Fig. 3c ) and 70% (not shown, scaled data from Fig. 3b ) reduction in hemifusion yield for SUP and PELLET, respectively. Since SUPlike particles represent approximately 50% of the PELLET (Table 1) , the loss of fusing particles determined for the SUP can account for 40% loss in the PELLET; the remaining 30% must have resulted from inhibition of long particles, and the long-particle yield is thus 70% (Fig. 3c ). For samples where PELLET yield-reduction was not greater than that predicted from the SUP data, long-particle yield was set to 100%.
We performed bi-gamma fitting of the PELLET lag-time distributions (Fig. 3a, bottom) using the following formula, Here, p Gamma (t; N, k) is the probability density function of the Gamma distribution with rate k and shape parameter N, and f1 is the fraction of population whose distribution is represented by (N1, k1) or the SUP-like particles, with the remainder sampling a (N2, k2) or the long-particle distribution. f1, k1, and N1 values were fixed, and N2, and k2 were derived from the fits. To fix values, k1 and N1 were derived from single-gamma fitting of the SUP data (Fig. 3a, top/red lines) . f1was calculated as follows. From the SUP-and long-particle yield values (Y SUP and Y PELLET ) ( Fig.  3c) , we calculated the fraction of the observed hemifusion events contributed by the long particles in the PELLET, f long = Y long / (Y long * 0.5 + Y SUP * 0.5). The two yield values were multiplied by 0.5 because SUP-like particles represent approximately 50% of the PELLET (Table 1) . f1 was fixed at (1-f long ). We show the bi-gamma fit curves (black lines), and the underlying curves for long (blue lines) and SUP-like particles (red lines) in the PELLET (Fig. 3a, bottom) .
Particle fluorescence-intensity measurements. The intensity analysis consists of three codes. The first code averages the first 10 frames of the particle movies (M-Fab-JF549 particles) and the no-particle movie (background), and subtracts the background image from the averaged particle images. The second code plots the background-processed image and prompts the user to manually draw regions of interest (masks) around particles whose intensity is to be quantified. Manual masks were preferred in this case because of the long particles that can be mistaken for multiple particles by automated particle-detection codes. The third code then integrates intensities within the masks.
Infectivity measurements
scTCID50. Virus was pre-incubated with or without M-Fab in OptiMEM for 30 minutes at RT, then serially diluted 4-fold in the same media. Trypsin was omitted to prevent activation of the released virus and new rounds of infection. Confluent monolayers of MDCK.2 cells in 96-well plates were washed with HBSS twice, and 100 µl of the virus dilutions were added to wells. The highest input virus concentration was 2-7*10 3 HAU/ml. Cells were fixed 24 hrs post infection with 3.7% formaldehyde, then stained with crystal violet. Plates were scanned using Gel Doc (Biorad), and the extent of cell death in each well evaluated by densitometry using ImageJ. The densitometry value in wells with complete cell death (background) was subtracted from all measurements, and the amount of cell death quantified relative to wells with no cell death. scTCID 50 titer is derived from the resultant plots of cell death versus particle concentration as the inverse of the particle concentration that resulted in 50% cell death. Relative reduction in infectivity was quantified as the ratio of scTCID 50 values for the untreated (baseline) and M-Fab-treated samples. We obtained the same baseline titers (tested with WT and H17 1 Y PELLET and SUP) when new rounds of infection were additionally prevented by the addition of 20 mM ammonium chloride 42 4-hours post infection, confirming that our experimental setup resulted in a single-cycle of infection. For
